• Sarepta Therapeutics EPS for the quarter ending March 31, 2025 was $-4.60, a 1343.24% decline year-over-year.
• Sarepta Therapeutics 2024 annual EPS was $2.34, a 140.34% decline from 2023.
• Sarepta Therapeutics 2023 annual EPS was $-5.8, a 27.77% decline from 2022.
• Sarepta Therapeutics 2022 annual EPS was $-8.03, a 55.92% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.